San Lorenzo Gold Corp. has filed a Second Amended and Restated Offering Document to increase its private placement to $80 million by offering up to 15,094,400 shares at $5.30 each. The offering now includes shares available to investors in the US and outside Canada under certain exemptions, expanding beyond the original Canadian-only offering. This move aims to raise significant capital to advance its Salvadora Project in Chile. Investors are advised to review the updated offering document before investing, with the company emphasizing compliance with applicable securities laws.
San Lorenzo Gold Corp.'s recent filing is presented here with Basic Materials sector data from Pluang. For readers following Basic Materials, 31 of 83 priced US stocks rose and 52 fell today. Notable movers include GGB at USD 4.77 (+5.76%), KGC at USD 21.70 (-5.57%) with a Pluang order activity of 40% Sell / 60% Buy, and IP at USD 36.25 (+5.13%). This data is as of Oct 29, 2026 22:21 WIB.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
